- Home
- ACEL vs ARVN Comparison
ACEL vs ARVN Comparison
Compare ACEL & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACEL | ARVN |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 942.7M | 781.0M |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ACEL | ARVN |
|---|---|---|
| Price | $11.04 | $10.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 20 |
| Target Price | $14.67 | ★ $15.35 |
| AVG Volume (30 Days) | 363.3K | ★ 785.5K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 46.34 | ★ 58.84 |
| EPS | ★ 0.60 | N/A |
| Revenue | N/A | ★ $262,600,000.00 |
| Revenue This Year | $7.07 | N/A |
| Revenue Next Year | $2.81 | N/A |
| P/E Ratio | $18.42 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.17 | $5.90 |
| 52 Week High | $13.31 | $14.22 |
Technical Indicators
Market Signals| Indicator | ACEL | ARVN |
|---|---|---|
| Relative Strength Index (RSI) | 47.93 | 42.68 |
| Support Level | $10.87 | $9.02 |
| Resistance Level | $11.59 | $14.03 |
| Average True Range (ATR) | 0.30 | 0.63 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 48.43 | 35.04 |
Price Performance
Historical ComparisonAbout ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.